Waldencast (WALD) to Release Quarterly Earnings on Monday

Key Points

• Waldencast (WALD) is set to release its Q2 2025 earnings results on August 18th, with analysts predicting earnings of ($0.10) per share and revenue of $71.93 million.
• Waldencast's stock opened at $1.64, showing a 12-month trading range between $1.60 and $4.74, with a consensus price target of $5.11 from analysts.
• Institutional investors hold 41.97% of Waldencast's stock, with significant recent maneuvers including a 62.2% increase in holdings by Geode Capital Management.

Waldencast (NASDAQ:WALD - Get Free Report) is anticipated to announce its Q2 2025 earnings results before the market opens on Monday, August 18th. Analysts expect the company to announce earnings of ($0.10) per share and revenue of $71.93 million for the quarter.

Waldencast Price Performance

NASDAQ:WALD traded down $0.09 during trading hours on Thursday, hitting $1.84. The company's stock had a trading volume of 56,577 shares, compared to its average volume of 103,505. The business's 50-day moving average is $2.27 and its two-hundred day moving average is $2.69. The company has a current ratio of 1.35, a quick ratio of 0.66 and a debt-to-equity ratio of 0.21. Waldencast has a 52-week low of $1.60 and a 52-week high of $4.74.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Rhumbline Advisers boosted its position in Waldencast by 15.2% during the 1st quarter. Rhumbline Advisers now owns 61,630 shares of the company's stock worth $185,000 after acquiring an additional 8,151 shares during the period. Invesco Ltd. acquired a new position in Waldencast during the second quarter valued at $26,000. Jane Street Group LLC acquired a new position in Waldencast in the 1st quarter worth about $77,000. Finally, Geode Capital Management LLC increased its position in Waldencast by 62.2% in the 2nd quarter. Geode Capital Management LLC now owns 586,566 shares of the company's stock worth $1,437,000 after purchasing an additional 224,905 shares during the last quarter. Institutional investors and hedge funds own 41.97% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on WALD shares. Wall Street Zen cut Waldencast from a "hold" rating to a "sell" rating in a research report on Thursday, May 22nd. Telsey Advisory Group reissued an "outperform" rating and issued a $4.00 price target on shares of Waldencast in a research note on Wednesday. Canaccord Genuity Group decreased their price target on Waldencast from $6.00 to $5.00 and set a "buy" rating on the stock in a research note on Thursday, May 15th. Industrial Alliance Securities set a $5.00 price target on Waldencast in a research note on Tuesday, April 22nd. Finally, Alliance Global Partners reissued a "buy" rating on shares of Waldencast in a research note on Thursday, May 15th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $5.11.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.